These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16369291)

  • 41. QT interval prolongation and antiretroviral treatment: another point of interest.
    Chinello P; Petrosillo N
    Clin Infect Dis; 2007 May; 44(10):1388-9; author reply 1389-91. PubMed ID: 17443482
    [No Abstract]   [Full Text] [Related]  

  • 42. A low antiretroviral activity of the antihepatitis B drug entecavir may be enough to select for M184V in HIV-1.
    Soriano V; Vispo E; Labarga P; Barreiro P
    AIDS; 2008 Apr; 22(7):911-2. PubMed ID: 18427216
    [No Abstract]   [Full Text] [Related]  

  • 43. Virological characterization of an infection with a dual-tropic, multidrug-resistant HIV-1 and further evolution on antiretroviral therapy.
    Masquelier B; Capdepont S; Neau D; Peuchant O; Taupin JL; Coakley E; Lie Y; Carpentier W; Dabis F; Fleury HJ;
    AIDS; 2007 Jan; 21(1):103-6. PubMed ID: 17148975
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Editorial comment: the head bone is connected to the body bone.
    Fichtenbaum CJ
    AIDS Read; 2008 May; 18(5):265. PubMed ID: 18589481
    [No Abstract]   [Full Text] [Related]  

  • 45. Liver triglyceride content in HIV-1-infected patients on combination antiretroviral therapy studied with 1H-MR spectroscopy.
    Moreno-Torres A; Domingo P; Pujol J; Blanco-Vaca F; Arroyo JA; Sambeat MA
    Antivir Ther; 2007; 12(2):195-203. PubMed ID: 17503662
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy: incidence and risk factors.
    Corral I; Quereda C; Moreno A; Pérez-Elías MJ; Dronda F; Casado JL; Muriel A; Masjuán J; Alonso-de-Leciñana M; Moreno S
    Cerebrovasc Dis; 2009; 27(6):559-63. PubMed ID: 19390181
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antiretroviral therapy increases risk of heart attack.
    Gottlieb S
    BMJ; 2003 Nov; 327(7425):1186. PubMed ID: 14630739
    [No Abstract]   [Full Text] [Related]  

  • 48. A comment on "Does first line antiretroviral therapy increase the prevalence of cardiovascular risk factors in Indian patients?: a cross sectional study".
    Raina SK
    J Postgrad Med; 2014; 60(2):226. PubMed ID: 24823544
    [No Abstract]   [Full Text] [Related]  

  • 49. Liver steatosis in Chinese HIV-infected patients with hypertriglyceridemia: characteristics and independent risk factors.
    Xiao J; Han N; Yang D; Zhao H
    Virol J; 2013 Aug; 10():261. PubMed ID: 23941464
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Recurrent pancreatitis in a human immunodeficiency virus-infected patient on antiretroviral therapy].
    Grandes Ibáñez J; Ocampo Hermida A; Longueira Suárez R; Lourido Cebreiro T
    Med Clin (Barc); 2010 Apr; 134(11):512. PubMed ID: 20045123
    [No Abstract]   [Full Text] [Related]  

  • 51. The possible role of antiretroviral drugs in the pathogenesis of progressive macular hypomelanosis.
    Lo Schiavo A; Gambardella A; Caccavale S
    Int J Dermatol; 2014 Jun; 53(6):759-60. PubMed ID: 23786465
    [No Abstract]   [Full Text] [Related]  

  • 52. Curing stigma--the limits of antiretroviral access.
    Blackstock O
    N Engl J Med; 2005 Aug; 353(8):752. PubMed ID: 16120853
    [No Abstract]   [Full Text] [Related]  

  • 53. Antiretroviral therapy and dyslipidaemia: unlocking the code.
    Mallon PW
    PLoS Med; 2006 Mar; 3(3):e85. PubMed ID: 16420104
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dilated cardiomyopathy in three HIV-infected children after initiation of antiretroviral therapy.
    Oberdorfer P; Sittiwangkul R; Puthanakit T; Pongprot Y; Sirisanthana V
    Pediatr Int; 2008 Apr; 50(2):251-4. PubMed ID: 18353072
    [No Abstract]   [Full Text] [Related]  

  • 55. Elevated blood pressure and correlates in a cohort of HIV-infected adults who started antiretroviral therapy when undernourished.
    PrayGod G; Changalucha J; Kapiga S; Todd J; Filteau S; Peck R
    J Clin Hypertens (Greenwich); 2017 Aug; 19(8):803-806. PubMed ID: 28548437
    [No Abstract]   [Full Text] [Related]  

  • 56. Importance of spontaneous reporting of adverse reactions associated with antiretroviral drugs in patients with the Human Inmunodeficiency Virus.
    Gallego-Muñoz C; Guerrero-Navarro N; Lorenzo-Martín S
    Enferm Clin; 2017; 27(2):138-139. PubMed ID: 27817983
    [No Abstract]   [Full Text] [Related]  

  • 57. DART and laboratory monitoring of HIV treatment.
    Peter T; Blair D; Reid M; Justman J
    Lancet; 2010 Mar; 375(9719):979. PubMed ID: 20304233
    [No Abstract]   [Full Text] [Related]  

  • 58. White blood: the tip of the iceberg?
    van Wolfswinkel ME; Banda PK; Glover SJ; van Oosterhout JJ
    Lancet; 2009 Nov; 374(9704):1866. PubMed ID: 19944868
    [No Abstract]   [Full Text] [Related]  

  • 59. HIV-AIDS in Tanzania--realities on the ground.
    Zeeman B
    N Engl J Med; 2006 Nov; 355(22):2276-7. PubMed ID: 17135581
    [No Abstract]   [Full Text] [Related]  

  • 60. Short-term effectiveness and safety of third-line antiretroviral regimens among patients in Western India.
    Pujari SN; Makane A; Lodha A; Bele V; Joshi K
    J Acquir Immune Defic Syndr; 2014 Feb; 65(2):e82-4. PubMed ID: 24442229
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.